| Name | Relationship | Address | Signature | Signature date | CIK |
|---|---|---|---|---|---|
| Blunt Christopher O | Chief Executive Officer, Director | 801 GRAND AVENUE, SUITE 2600, DES MOINES | /s/ Tessa Cantonwine, attorney-in-fact | 2025-11-13 | 0001662378 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | FG | Common Stock | Award | $0 | +260K | +28.65% | $0.00 | 1.17M | Nov 10, 2025 | Direct | F1, F2 |
| Id | Content |
|---|---|
| F1 | Grant of restricted common stock vesting in three equal annual installments beginning November 10, 2026, subject to the achievement of performance criteria specified in the reporting person's award agreement. |
| F2 | Reflects purchases under the Company's ESPP plan which are not required to be reported on an ongoing basis. The purchases are being reported on this Form 4 to accurately reflect the reporting person's ownership of the issuer's shares as of the current date. |